Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate plus alfentanil versus propofol sedation for painless gastroscopy
ChiCTR2300077252Phase 4Recruiting
- Sponsor
- The First Hospital of Lanzhou University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam, alfentanil and propofol (2 arms), sponsored by The First Hospital of Lanzhou University. Primary endpoint: Hemodynamic and oxygenation parameters during the trial. Started Nov 2023; status: recruiting.
02
Drugs
remimazolamalfentanilpropofol
Beyond the preview
Go deeper on ChiCTR2300077252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077252.